 | FY2022 Earnings Estimate for VYNE Therapeutics Inc. Issued By Cantor Fitzgerald (NASDAQ:VYNE)
americanbankingnews.com - May 7 at 11:35 AM |
| VYNE Therapeutics (NASDAQ:VYNE) PT Lowered to $11.00 at HC Wainwright
americanbankingnews.com - May 7 at 9:15 AM |
 | VYNE Therapeutics Inc. (VYNE) Q1 2021 Earnings Call Transcript
fool.com - May 7 at 1:08 AM |
 | VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates
msn.com - May 6 at 11:42 AM |
 | VYNE Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - May 6 at 7:49 AM |
| VYNE Therapeutics Inc. (NASDAQ:VYNE) Receives Average Recommendation of "Buy" from Brokerages
americanbankingnews.com - May 6 at 1:42 AM |
| VYNE Therapeutics (VYNE) Scheduled to Post Quarterly Earnings on Thursday
americanbankingnews.com - May 5 at 6:58 AM |
 | VYNE Therapeutics earnings preview: what Wall Street is expecting
markets.businessinsider.com - May 4 at 5:45 PM |
| $5.08 Million in Sales Expected for VYNE Therapeutics Inc. (NASDAQ:VYNE) This Quarter
americanbankingnews.com - May 2 at 2:54 AM |
| -$0.40 Earnings Per Share Expected for VYNE Therapeutics Inc. (NASDAQ:VYNE) This Quarter
americanbankingnews.com - April 30 at 8:35 AM |
|
| VYNE Therapeutics (VYNE) to Release Quarterly Earnings on Thursday
americanbankingnews.com - April 29 at 8:52 AM |
| VYNE Therapeutics to Report First Quarter 2021 Financial Results on May 6, 2021
finance.yahoo.com - April 28 at 9:25 AM |
| VYNE Therapeutics'(NASDAQ:VYNE) Share Price Is Down 11% Over The Past Year.
finance.yahoo.com - April 22 at 3:00 PM |
| Zacks: Analysts Expect VYNE Therapeutics Inc. (NASDAQ:VYNE) Will Announce Quarterly Sales of $5.08 Million
americanbankingnews.com - April 15 at 1:56 AM |
| Zacks: Analysts Expect VYNE Therapeutics Inc. (NASDAQ:VYNE) Will Announce Earnings of -$0.40 Per Share
americanbankingnews.com - April 13 at 10:42 AM |
| Outlook on the Acne Treatment Global Market to 2025 - Players Include Vyne Therapeutics, Bausch Health Companies and Abbvie
finance.yahoo.com - March 30 at 8:05 AM |
| The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes
markets.businessinsider.com - March 17 at 7:59 AM |
 | VYNE Therapeutics EPS beats by $0.08, misses on revenue
seekingalpha.com - March 5 at 2:39 PM |
| VYNE Therapeutics to Present at Upcoming Virtual Investor Conferences
finance.yahoo.com - March 4 at 6:36 PM |
| VYNE Therapeutics Inc. (VYNE) Q4 2020 Earnings Call Transcript
fool.com - March 4 at 1:59 PM |
| VYNE Therapeutics Inc. (VYNE) Reports Q4 Loss, Misses Revenue Estimates
msn.com - March 4 at 1:36 PM |
| VYNE Therapeutics Inc to Host Earnings Call
finance.yahoo.com - March 4 at 8:35 AM |
| VYNE Therapeutics to Present at the Cowen 41st Annual Health Care Conference
finance.yahoo.com - March 1 at 5:34 PM |
| VYNE Therapeutics Announces Development Program for FMX114 Combination Topical Gel for Mild-to-Moderate Atopic Dermatitis
finance.yahoo.com - March 1 at 10:10 AM |
| VYNE THERAPEUTICS -,0001 (26J.BE)
ca.finance.yahoo.com - February 18 at 7:03 PM |
| What You Need To Know About The VYNE Therapeutics Inc. (NASDAQ:VYNE) Analyst Downgrade Today
finance.yahoo.com - February 17 at 8:05 AM |
| VYNE Therapeutics Announces Reverse Stock Split
finance.yahoo.com - February 11 at 8:44 AM |
 | Thinking about buying stock in Canopy Growth Corp, 3D Systems, Bilibili, Agenus, or Vyne Therapeutics?
marketwatch.com - February 4 at 12:07 PM |
| VYNE Therapeutics Announces FDA Approval of AMZEEQ(R) (Minocycline) Label Update
marketwatch.com - February 2 at 12:34 PM |
| Why Vir Biotech, Concert Pharma And More Are Moving Today
markets.businessinsider.com - February 1 at 12:48 PM |
|
| VYNE Therapeutics Announces FDA Approval of AMZEEQ® (Minocycline) Label Update
finance.yahoo.com - February 1 at 9:15 AM |
| VYNE Therapeutics Announces Closing of $50 Million Registered Direct Offering of Common Stock and Provides Corporate Update
finance.yahoo.com - January 29 at 12:45 PM |
 | Can Vyne Therapeutics Stock Keep Soaring?
nasdaq.com - January 28 at 9:56 AM |
| VYNE Therapeutics Announces $50 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
finance.yahoo.com - January 26 at 9:23 AM |
 | ROCE Insights For VYNE Therapeutics
benzinga.com - January 25 at 1:36 PM |
| VYNE Therapeutics Announces Contract Execution for AMZEEQ® (minocycline) and ZILXI® (minocycline) with Major Pharmacy Benefit Management (PBM) Company
finance.yahoo.com - January 21 at 9:14 AM |
| VYNE Therapeutics to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event this Week
finance.yahoo.com - January 5 at 8:26 AM |
| VYNE Therapeutics Inc. (NASDAQ:VYNE): Are Analysts Optimistic?
finance.yahoo.com - December 24 at 12:56 PM |
 | VYNE Therapeutics Inc
bloomberg.com - December 19 at 11:04 PM |
| VYNE Therapeutics Reports Successful End-of-Phase 2 Meeting with the FDA for FCD105 in Acne
finance.yahoo.com - December 17 at 9:47 AM |
| VYNE Therapeutics Added to Nasdaq Biotechnology Index
finance.yahoo.com - December 16 at 12:33 PM |
| VYNE Therapeutics Announces New U.S. Patent Expiring in 2037 for AMZEEQ® (minocycline) topical foam, 4%
finance.yahoo.com - December 15 at 10:12 AM |
| Is VYNE A Good Stock To Buy Now?
finance.yahoo.com - December 9 at 11:13 PM |
| VYNE Therapeutics Announces Publication of Long-term Safety & Efficacy Data for ZILXI™ (minocycline) topical foam, 1.5% in the Journal of Clinical and Aesthetic Dermatology
finance.yahoo.com - December 1 at 1:13 PM |
| VYNE Therapeutics (VYNE) CEO David Domzalski on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 3:27 PM |
| US$7.07 - That's What Analysts Think VYNE Therapeutics Inc. (NASDAQ:VYNE) Is Worth After These Results
finance.yahoo.com - November 9 at 1:50 PM |
| Foamix Pharmaceuticals Ltd (FOMX) CEO David Domzalski on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 1:05 PM |
| VYNE Therapeutics EPS beats by $0.02, beats on revenue
seekingalpha.com - November 5 at 8:31 AM |
| VYNE Therapeutics to Report Third Quarter 2020 Financial Results on November 5th
finance.yahoo.com - October 28 at 8:42 AM |
| VYNE Therapeutics' Zilxi foam added to Express Scripts coverage
seekingalpha.com - October 7 at 2:03 PM |
